Many groups are working to discover new, safer ways to deliver drugs that fight cancer to the tumor without damaging healthy cells. Others are finding ways to boost the body’s own immune system to attack cancer cells. For the first time, researchers at Penn State have combined the two approaches by conjugating biodegradable polymer nanoparticles encapsulated with chosen cancer-fighting drugs into immune cells to create a smart, targeted system to attack cancers of specific types.
“The traditional way to deliver drugs to tumors is to put the drug inside some type of nanoparticle and inject those particles into the bloodstream,” said Jian Yang, professor of biomedical engineering, Penn State. “Because the particles are so small, if they happen to reach the tumor site they have a chance of penetrating through the blood vessel wall because the vasculature of tumors is usually leaky.”
The odds of interacting with cancer cells can be improved by coating the outside of the nanoparticles with antibodies or certain proteins or peptides that will lock onto the cancer cell when they make contact. However, this is still a passive drug delivery technology. If the particle does not go to the tumor, there is no chance for them to bind and deliver the drug.
Yang and Cheng Dong, department head and distinguished professor of biomedical engineering, wanted a more active method of targeting drugs to the cancer wherever it was located, whether circulating in the blood, or in the brain or in any of the other organs of the body.
“I have 10 years of working in immunology and cancer,” Dong said. “Jian is more a biomaterials scientist. He knows how to make the nanoparticles biodegradable. He knows how to modify the particles with surface chemistry, to decorate them with peptides or antibodies. His material is naturally fluorescent, so you can track the particles at the same time they are delivering the drug, a process called theranostics that combines therapy and diagnostics. On the other hand, I study the cancer microenvironment, and I have discovered that the microenvironment of the tumor generates kinds of inflammatory signals similar to what would happen if you had an infection.”
Immune cells, which were built to respond to inflammatory signals, will be naturally attracted to the tumor site. This makes immune cells a perfect active delivery system for Yang’s nanoparticles. The same technology is also likely to be effective for infectious or other diseases, as well as for tissue regeneration, Dong said.
In the first proof of their technology, the two research groups targeted circulating melanoma cells. In a paper published in the current online issue of the journal Small, titled “Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting,” the researchers report the use of a novel biodegradable and photoluminescent poly (lactic acid) (BPLP-PLA) nanoparticle, loaded with melanoma-specific drugs with immune cells as the nanoparticle carriers. They showed that the immune cells could bind to the melanoma cells under shear stress conditions similar to those in the bloodstream. These experiments were all performed outside the body. Next they intend to perform studies in animal models and in solid tumors.
“This is the first study and is just to show that the technology works,” Dong said. “This study is not about curing melanoma. There are probably other ways to do that. We used melanoma cells to validate the approach.”
Receive an email update when we add a new DRUG DELIVERY article.
The Latest on: Nanoparticle drug delivery
via Google News
The Latest on: Nanoparticle drug delivery
- Nanoscale Virus Trap Molecule Analysis and In-depth Research on Market Size, Trends, Emerging Growth and Forecast 2018-2026 on February 20, 2019 at 8:32 am
The nanoparticle molecule is composed of compounds found naturally ... research has led to the emergence of new technologies that has the potential to improve drug delivery and effectiveness. With evo... […]
- Injectable hydrogel lines up for multiple drug delivery on February 19, 2019 at 3:28 am
The application of hydrogel scaffolds to the clinic is currently hindered by two major hurdles: scalability and the invasive nature of delivery techniques ... (ethylene glycol)‐block‐poly(lactic acid) ... […]
- Robust and Repeatable Nanoparticle Drug Delivery Characterization with FFF-MALS-DLS on February 18, 2019 at 7:22 pm
Nanoparticles hold enormous potential for taRgeted, well-controlled drug delivery. Extensive characterization of nanoscale drug-delivery vehicles is essential to ensure their efficacy and reproducibil... […]
- MRI Guided Drug Delivery Market Size, Industry Status and Forecast 2018-2028 on February 18, 2019 at 9:13 am
MRI guided drug delivery or magnetic resonance guided drug delivery is ... The MRI guided delivery system uses multifunctional super-paramagnetic iron oxide (SPIO)-based nanoparticles as a nano-system ... […]
- Could gold ash be a magic bullet for treating cancer? on February 16, 2019 at 5:52 pm
She’s referring to drug delivery — the idea that gold ash ... ash particles to deliver cancer treatments in ways that other nanoparticles cannot. “They’ve been using these nanoparticles ... […]
- The Future of Medicine is at the Nanoscale on February 15, 2019 at 1:56 pm
Ideally, nanotech developed for targeted drug delivery needs to fulfill multiple objectives designed to improve the effectiveness of treatment: Nanoparticles and nanoengineered devices are nanotech me... […]
- Chemo-Carrying Gold Nanoparticles Tested on Mesothelioma on February 12, 2019 at 6:53 am
Researchers published the study in January in the International Journal of Nanomedicine. “The use of nanoparticles as innovative drug delivery vehicles that specifically target against a range of dise... […]
- Sitka raises $1.2 mln to advance bladder cancer treatment on February 11, 2019 at 12:05 pm
Sitka is developing a nanoparticle platform to increase the absorption of ... intraperitoneal delivery for ovarian cancer and other indications where localized drug delivery would be advantageous but ... […]
- Nanoparticles Market Outlook to 2026 - Johnson & Johnson, Novartis, Amgen, Hitachi, Gilead Sciences on February 9, 2019 at 7:31 am
A long circulating particle made up of Biodegradable polymeric nanoparticles with hydrophilic polymer coating of poly ethylene glycol (PEG), used as a powerful drug delivery device. Due to its ability ... […]
via Bing News